Home LiteratureArticle Details
PMID: 27001510 Published · ppublish English

Involvement of budding yeast Rad5 in translesion DNA synthesis through physical interaction with Rev1.

Nucleic acids research ·Vol. 44 ·No. 11 ·0000-00-00

Xu Xin, Lin Aiyang, Zhou Cuiyan, Blackwell Susan R, Zhang Yiran, Wang Zihao, Feng Qianqian, Guan Ruifang, Hanna Michelle D, Chen Zhucheng, Xiao Wei

Abstract

DNA damage tolerance (DDT) is responsible for genomic stability and cell viability by bypassing the replication block. In Saccharomyces cerevisiae DDT employs two parallel branch pathways to bypass the DNA lesion, namely translesion DNA synthesis (TLS) and error-free lesion bypass, which are mediated by sequential modifications of PCNA. Rad5 has been placed in the error-free branch of DDT because it contains an E3 ligase domain required for PCNA polyubiquitination. Rad5 is a multi-functional protein and may also play a role in TLS, since it interacts with the TLS polymerase Rev1. In this study we mapped the Rev1-interaction domain in Rad5 to the amino acid resolution and demonstrated that Rad5 is indeed involved in TLS possibly through recruitment of Rev1. Genetic analyses show that the dual functions of Rad5 can be separated and reconstituted. Crystal structure analysis of the Rad5-Rev1 interaction reveals a consensus RFF motif in the Rad5 N-terminus that binds to a hydrophobic pocket within the C-terminal domain of Rev1 that is highly conserved in eukaryotes. This study indicates that Rad5 plays a critical role in pathway choice between TLS and error-free DDT.

Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
Published
0000-00-00
Indexed
2016-06-21
Updated
2016-06-23
Language
English
Country/Region
England
NLM ID
0411011
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com